An electrohydraulic ventricular assist system with a linear actuator.

Area of Science:

• Biomedical Engineering
• Cardiovascular Science
• Medical Devices

Background:

• Heart failure is a significant global health concern requiring advanced therapeutic solutions.
• Ventricular assist devices (VADs) are crucial for managing end-stage heart failure.
• Existing VADs face challenges in durability and efficiency.

Purpose of the Study:

• To develop and evaluate a novel electrohydraulic ventricular assist system.
• To assess the performance and durability of the system through in vitro and in vivo testing.
• To determine the system's capacity to maintain stable hemodynamics under varying physiological conditions.

Main Methods:

• Development of an electrohydraulic VAD incorporating a linear actuator.
• In vitro testing to measure pump flow against simulated afterload conditions.
• In vivo implantation in three goats for hemodynamic performance evaluation.
• Durability testing exceeding four months.

Main Results:

• The system achieved a pump flow of 5.6 L/min against a 100 mmHg afterload in vitro.
• In vivo, the system delivered a maximum pump flow of 4.2 L/min at 100 mmHg and 3.2 L/min at 130 mmHg.
• The VAD demonstrated sustained stable hemodynamic performance across tested conditions.
• Durability tests confirmed system integrity for over four months.

Conclusions:

• The developed electrohydraulic ventricular assist system is effective and durable.
• The system shows promise for supporting cardiac function and maintaining stable hemodynamics.
• This technology represents a potential advancement in VAD therapy for heart failure patients.